Budesonide-MMX 9 mg
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Budesonide-MMX 9 mg, covering 2014-06-05 to 2019-09-06. Get the full timeline:
Most recent: Clinical Trial Update: Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA) [Phase 3]